| Tag | Content |
|---|
EnhancerAtlas ID | HS120-02848 |
Organism | Homo sapiens |
Tissue/cell | LNCaP-abl |
Coordinate | chr17:56464980-56466620 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| RREB1 | MA0073.1 | chr17:56465336-56465356 | CCACCACACACACCCCCTCC | + | 6.15 | | RREB1 | MA0073.1 | chr17:56465334-56465354 | CCCCACCACACACACCCCCT | + | 6.2 | | RREB1 | MA0073.1 | chr17:56465332-56465352 | CCCCCCACCACACACACCCC | + | 7.16 |
|
| | Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
| SE_23473 | chr17:56465369-56466136 | Colon_Crypt_1 | | SE_28098 | chr17:56464879-56466177 | Fetal_Intestine | | SE_28995 | chr17:56464683-56466467 | Fetal_Intestine_Large | | SE_34462 | chr17:56464248-56466579 | HCT-116 | | SE_50030 | chr17:56465036-56470585 | RPMI-8402 | | SE_52476 | chr17:56465332-56466329 | Small_Intestine | | SE_56729 | chr17:56465553-56466535 | VACO_400 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr17 | 56465179 | 56466437 | | chr17 | 56466028 | 56466122 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I058387 | chr17 | 56464801 | 56466350 |
|
Enhancer Sequence | ACTGCTCTCC AGCCTGGGCG ACAGAGAGAG ACTCCATCTT CAAAAAAAAA ACAAAAAAAC 60
AAAGTGCAGG ACACCTATAA AAGTCAACTA CTATTAGATT GACAATGACA ATGGCTTCAC 120
TGAAAACAAA AGCAGATCCA AAAAGTTCCG AATAGTTCTG AATATGGCTC AGCTAAGATA 180
TAACTATCTT ACTCTGGCTT TCATCCAATA CATTTCCTCT TGGCCCAGTT AGCAAATGGG 240
TAATTATATG ACATCAGCCA CCATGGGGTG GCTGGGACAT AAGGTGGCTT CATGGTGCCA 300
TATAATGTGG CACCAAGTTT CTTAATCACC AACCACAGGT GCATCAACTC TTCCCCCCAC 360
CACACACACC CCCTCCATAA AACCACCTTA TCTGATATTT CTGTTGACAC AGTGACTATG 420
CTTCAGGCAC TTTCCTTTGC TTCTTCTTAA TGTTTGTTCG GGTGGGTACC TCTGTGCAGA 480
TGCCTATAAA TGAGTTCTTA GGGTATAGGA GTAACCACCC AGTCATCAGG CCATACTTTT 540
GTTTTTAGGC AGGCTTAACT CAGAAAGTAG CAGCATATGT AATTGCTAAG CCAAAACCTA 600
CCTGAAATAC TTCAGAGGCT AAGCCCCTTT CCTAGCCAAA TACCTAACTA CTAGAGTTGC 660
TCTCTGTCAG TAAGTTGATT CCTTGCCTGC ACATTATCAG ACCTGTTTCT GGAGCCATCT 720
TTCTCCCTAA AATGACAGCT GCTACAGTTT CCCCCAAACC CTTTGTGACA CGGCATATCA 780
ATGGCTCCCA AGTGATCCTT GTCAAGAAAC AGAGACTCAC TTCATGTGAC CACTGAGTAC 840
AATGCTGGAT GGGCATGCAC AGAGATTTCC CTCACAGGTA CATCAGAATG GGTCTGAAAT 900
ATGGCCTCTT ACTTGGCAAG TATTTGATGA GCACCTATCT TCTTCCCAAA ACTGTTAGGT 960
CCAACCCAGG AGGTACATTC TCACTGGGGA GATGACATAT ACACAAAGTA AATGGTGGTA 1020
CAAAACGACA TTGTATCAAA GGCCACATTG TGTGGTAAAG CCAATAGGTC CTACAGGATT 1080
TGTCAAGGAG ATGGATCTTA AGCTCACCCT TAAAGACAAC AGAATTTGGA CAGGAAAAAA 1140
ATAGCCACAG GATCTAGTCC ACTGGGATCT GTCAAATGGA TTTTTCAAAC TTCTGAGCTT 1200
ACTTGAGAAG AAACCAGGAG CCAGGTGAGA GAAAAAGTAA GGTTCTTGAG CAGTTTCTCT 1260
CAAGTCTTCA GGGTACAGGA AGACTTGTCT GACTGAAAAA ATAGATCTGC AAAGATAGCT 1320
TGGATAGCTG AGGTAGGATC AAATTACAAA GGCTACTGCA TGCCAAGATG AGAGTTAGAG 1380
CTTGCTCTCA TATGCAAAAA AGGAATCATC CTAAATTCTT CAGGGGATCT CATTATCAAA 1440
ACAATACTGT AAGCAGAGCA ATTTAATAGC AGAGTAAACT AGTGCAATGA AGAGAAAACT 1500
AGTGGTAGGA AAATCAATTA GAGAGCTGTT CCAGTAATCT AGTACTGCAC GATCAGAGCT 1560
TGAACTCTGG TAGTAATAGT TAAAAGGAGA AGGAATTAAT TACAGAAATT ATGAAGGAAG 1620
TGTTGAAAGT ACTTGACAGA 1640
|
